NANOVIRICIDES, INC. Increase (Decrease) in Deferred Income Taxes
NANOVIRICIDES, INC. (NNVC) reported Increase (Decrease) in Deferred Income Taxes of $0 for the 86-month period ending 2012-06-30, per its 10-K/A filed 2012-10-26.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredIncomeTaxes · last filed 2012-10-26
- NANOVIRICIDES, INC. increase (decrease) in deferred income taxes for the quarter ending 2012-06-30 was $0.00.
- NANOVIRICIDES, INC. increase (decrease) in deferred income taxes for the quarter ending 2012-03-31 was $0.00, a 100.00% decline year-over-year.
- NANOVIRICIDES, INC. increase (decrease) in deferred income taxes for the quarter ending 2011-06-30 was $0.00.
- NANOVIRICIDES, INC. increase (decrease) in deferred income taxes for the quarter ending 2011-03-31 was $35.42K.
- NANOVIRICIDES, INC. increase (decrease) in deferred income taxes for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- NANOVIRICIDES, INC. increase (decrease) in deferred income taxes for fiscal 2011 was $22.92K, a 136.77% increase from fiscal 2010.
- NANOVIRICIDES, INC. increase (decrease) in deferred income taxes for fiscal 2010 was $9.68K.
| Period end | Increase (Decrease) in Deferred Income Taxes 3 month | Increase (Decrease) in Deferred Income Taxes 6 month | Increase (Decrease) in Deferred Income Taxes 9 month | Increase (Decrease) in Deferred Income Taxes 12 month | Increase (Decrease) in Deferred Income Taxes 80 month | Increase (Decrease) in Deferred Income Taxes 83 month | Increase (Decrease) in Deferred Income Taxes 86 month |
|---|---|---|---|---|---|---|---|
| 2012-06-30 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-10-26 | $0.00 derived: sum of 2 quarters · filed 2012-10-26 | $0.00 10-K/A · filed 2012-10-26 | $0.00 10-K/A · filed 2012-10-26 | |||
| 2012-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-21 | $0.00 10-Q · filed 2012-05-21 | $0.00 10-Q · filed 2012-05-21 | ||||
| 2011-12-31 | $0.00 10-Q · filed 2012-02-14 | $0.00 10-Q · filed 2012-02-14 | |||||
| 2011-06-30 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-10-26 | $35.42K derived: sum of 2 quarters · filed 2012-10-26 | $22.92K 10-K/A · filed 2012-10-26 | ||||
| 2011-03-31 | $35.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-21 | $22.92K 10-Q · filed 2012-05-21 | |||||
| 2010-12-31 | -$12.50K 10-Q · filed 2012-02-14 | ||||||
| 2010-06-30 | $9.68K 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |